References
- Howe S R, Gottardis M M, Everitt J I, Walker C. Estrogen stimulation and tamoxifen inhibition of leiomyoma cell growth in vitro and in vivo. Endocrinology 1995; 136: 4996–5003
- Maruo T, Ohara N, Wang J, Matsuo H. Sex steroidal regulation of uterine leiomyoma growth and apoptosis. Hum Reprod Update 2004; 10: 207–220
- Van de Ven J, Sprong M, Donker G H, Thijssen J H, Mak-Kregar S, Blankenstein M A. Levels of estrogen and progesterone receptors in the myometrium and leiomyoma tissue after suppression of estrogens with gonadotropin releasing hormone analogs. Gynecol Endocrinol 2001; 15: 61–68
- Leitao M M, Soslow R A, Nonaka D, Olshen A B, Aghajanian C, Sabbatini P, Dupont J, Hensley M, Sonoda Y, Barakat R R, et al. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma. Cancer 2004; 101: 1455–1462
- Houston K D, Copland J A, Broaddus R R, Gottardis M M, Fischer S M, Walker C L. Inhibition of proliferation and estrogen receptor signaling by peroxisome proliferators-activated receptor γ ligands in uterine leiomyoma. Cancer Res 2003; 63: 1221–1227
- Bourlev V, Pavlovitch S, Stygar D, Volkov N, Lindblom B, Olovsson M. Different proliferative and apoptotic activity in peripheral versus central parts of human uterine leiomyomas. Gynecol Obstet Invest 2003; 55: 199–204
- Mannhold R. KATP channel openers: structure–activity relationships and therapeutic potential. Med Res Rev 2004; 24: 213–266
- Challinor-Rogers J L, McPherson G A. Potassium channel openers and other regulators of KATP channels. Clin Exp Pharmacol Physiol 1994; 21: 583–597
- Harmon C S, Lutz D, Ducote J. Potassium channel openers stimulate DNA synthesis in mouse epidermal keratinocyte and whole hair follicle cultures. Skin Pharmacol 1993; 6: 170–178
- Wondergem R, Cregan M, Strickler L, Miller R, Suttles J. Membrane potassium channels and human bladder tumor cells: II. Growth properties. J Membr Biol 1998; 161: 257–262
- Woodfork K A, Wonderlin W F, Peterson V A, Strobl J S. Inhibition of ATP-sensitive potassium channels causes reversible cell-cycle arrest of human breast cancer cells in tissue culture. J Cell Physiol 1995; 162: 163–171
- Deutch C E, Hasler J M, Houston R M, Sharma M, Stone V J. Nonspecific inhibition of proline dehydrogenase synthesis in Escherichia coli during osmotic stress. Can J Microbiol 1989; 35: 779–785
- Jakimiuk A J, Ogusiewicz M, Tarkowski R, Dziduch P, Adamiak A, Wrobel A, Haczyriski J, Magoffin D A, Jakowicki J A. Estrogen receptor α and β expression in uterine leiomyomas from premenopausal women. Fertil Steril 2004; 82: 1244–1249
- Yokoshiki H, Sunagawa M, Seki T, Sperelakis N. ATP-sensitive K+ channels in pancreatic, cardiac, and vascular smooth muscle cells. Am J Physiol Cell Physiol 1998; 274: C25–C37
- Strobl J S, Wonderlin W F, Flynn D C. Mitogenic signal transduction in human breast cancer cells. Gen Pharmacol 1995; 26: 1643–1649
- Yao X, Kwan H Y. Activity of voltage-gated K+ channels is associated with cell proliferation and Ca2+ influx in carcinoma cells of colon cancer. Life Sci 1999; 65: 55–62
- Malhi H, Irani A N, Rajvanshi P, Suadicani S O, Spray D C, McDonald T V, Gupta S. KATP channels regulate mitogenically induced proliferation in primary rat hepatocytes and human liver cell lines. Implications for liver growth control and potential therapeutic targeting. J Biol Chem 2000; 275: 26050–26057
- Zhou Q, Kwan H Y, Chan H C, Jiang J L, Tam S C, Yao X. Blockage of voltage-gated K+ channels inhibits adhesion and proliferation of hepatocarcinoma cells. Int J Mol Med 2003; 11: 261–266
- Nilius B, Wohlrab W. Potassium channels and regulation of proliferation of human melanoma cells. J Physiol 1992; 445: 537–548
- Lee Y S, Sayeed M M, Wurster R D. Inhibition of cell growth and intracellular Ca2+ mobilization in human brain tumor cells by Ca2+ channel antagonists. Mol Chem Neuropathol 1994; 22: 81–95
- Wang Y F, Jia H, Walker A M, Cukierman S. K-current mediation of prolactin-induced proliferation of malignant (Nb2) lymphocytes. J Cell Physiol 1992; 152: 185–189
- Chegini N, Ma C, Tang X M, Williams R S. Effects of GnRH analogues, ‘add-back’ steroid therapy, antiestrogen and antiprogestins on leiomyoma and myometrial smooth muscle cell growth and transforming growth factor-β expression. Mol Hum Reprod 202; 8: 1071–1078
- Zaitseva M, Yue D S, Katzenellenbogen J A, Rogers P A, Gargett C E. Estrogen receptor-α agonists promote angiogenesis in human myometrial microvascular endothelial cells. J Soc Gynecol Investig 2004; 11: 529–535
- West C P, Lumsden M A, Lawson S, Williamson J, Baird D T. Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot. Fertil Steril 1987; 48: 45–51